NCT06464276View on ClinicalTrials.gov

Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The V-GOOD Study

CompletedOBSERVATIONAL

Enrollment

800

Participants

Timeline

Start Date

October 31, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

September 30, 2022

Conditions

Chronic Coronary SyndromeStable Angina

Interventions

OTHER

No intervention

No intervention

Trial Locations (1)

05403-000

InCor Heart Institute, São Paulo

All Listed Sponsors

collaborator

Servier

INDUSTRY

lead

Ministry of Health, Brazil

OTHER_GOV